SCHEMBL9368705

SCHEMBL9368705

CCc1ccc2[nH]c(=O)c(=O)n(O)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 4/20 0.48
PDE9A O76083 2/20 0.40
GRIA1 P42261 2/20 0.38
GRIA2 P42262 2/20 0.38
GRIA3 P42263 2/20 0.38
GRIA4 P48058 2/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
PARG Q86W56 1/20 0.38
PARP1 P09874 1/20 0.36
PDE2A O00408 1/20 0.36
PDE6D O43924 1/20 0.36
PDE8A O60658 1/20 0.36
PDE5A O76074 1/20 0.36
PDE8B O95263 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9364640 0.82 DAO (0.39) DAOGRIA1GRIA2GRIA3GRIA4
SCHEMBL9364786 0.82 KDM4E (0.51) DAOGRIA1GRIA2GRIA3GRIA4
SCHEMBL9364597 0.79 DAO (0.70) DAOALDH1A1MAPT
SCHEMBL9368648 0.76 DAO (0.44) DAOALDH1A1
SCHEMBL9364598 0.76 DAO (0.70) DAOGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8145145 0.76 DAO (0.70) DAO
SCHEMBL9365381 0.75 ALDH1A1 (0.48) DAOPARP1PDE3BPDE3AALDH1A1
SCHEMBL2802039 0.73 B3GNT2 (0.52) DAOGRIA1GRIA2GRIA3GRIA4
SCHEMBL12727792 0.72 MAOB (0.55) DAO
SCHEMBL2056352 0.72 GRIN2D (0.59) DAOGRIA1GRIA2GRIA3GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP claimed
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP disclosed
US-5061706-A 2,3-QUINOXALINEDIONES FOR USE AS NEUROLEPTICS NOVO NORDISK A/S (DK) 1991-10-29 US disclosed
EP-0377112-A1 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1990-07-11 EP disclosed